세계의 디지털 게놈 시장 규모는 향후 수년간 급성장이 전망됩니다. 예측 기간의 성장은 유전성질환의 유병률 증가, 디지털 게놈에 관한 연구개발 증가, 개별화 의료 채용 확대, 바이오테크놀러지 발전, 만성 질환의 유병률의 상승에 기인하고 있습니다. 예측 기간 중의 주요한 동향으로서는 차세대 시퀀싱 기술의 채용 증가, 기술 진보 증가, 진단 산업에 있어서의 미생물의 광범위한 이용, 맞춤형 의료에 대한 수요 증가, 병원이나 진료소에 있어서의 디지털 게놈 기술의 채용 증가 등을 들 수 있습니다.
유전성 질환의 유병률 증가는 향후 디지털 게놈 시장의 성장을 가속할 것으로 예상됩니다. 디지털 게놈 기술은 유전성 질환과 관련된 유전자 변이 및 돌연변이를 확인할 수 있게 해줍니다. 예를 들어, 2023년 8월, 미국의 의학 도서관인 국립 의학 도서관에 따르면, 겸상 적혈구 빈혈은 미국의 아프리카계 미국인의 약 500명에 1명이 이환하는 유전병입니다. 게다가 아프리카계 미국인 12명 중 한 명이 이 질병의 원인이 되는 상염색체 열성 돌연변이를 가지고 있으며, 연간 약 30만 명의 유아가 겸상 적혈구 빈혈로 태어나고 있습니다.
디지털 게놈 시장에서 사업을 전개하는 주요 기업은 NovaSeq X 시리즈와 같은 혁신적인 제품을 개발하고 질병을 이해하며 궁극적으로 환자의 삶을 변화시키는 것을 목표로 하고 있습니다. NovaSeq X 시리즈에는 NovaSeq X와 NovaSeq Plus 시스템이 있으며, NovaSeq X Plus는 회당 128개 이상의 유전체을 시퀀싱하여 연간 2만 개 이상의 전체 유전체을 생성할 수 있습니다. 2022년 9월, 미국의 바이오테크놀러지 기업인 Illumina, Inc.는 NovaSeq X 시리즈를 발표했습니다. 이 시스템은 전체 워크 플로우의 비용 효율성, 간소화된 인포매틱스, 지속성 향상 및 세계 수준의 지원을 통합하여보다 광범위하고 깊은 시퀀싱을 가능하게하며, 더 많은 샘플을 포함하는 용도의 스케일 업 및보다 효율적인 데이터 분석을 가능하게 합니다. NovaSeq X 시리즈는 시약 안정성을 향상시키고 유전체학 데이터 압축을 최적화하여 데이터 전송 속도를 높이는 가장 강력하고 비용 효율적인 시퀀싱 시스템으로 설계되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 디지털 게놈 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계 디지털 게놈 시장 : 성장률 분석
- 세계 디지털 게놈 시장 실적 : 규모와 성장, 2019-2024
- 세계 디지털 게놈 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 디지털 게놈 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 디지털 게놈 시장 : 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 시퀀싱 및 분석 장비
- 데이터 분석 및 관리 도구
- 세계의 디지털 게놈 시장 : 용도별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 진단
- 농업 및 동물조사
- 맞춤형 의료
- 창약
- 치료 분석
- 세계의 디지털 게놈 시장 : 최종 사용자별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 연구센터 및 정부기관
- 학술기관
- 제약 및 생명 공학 산업
- 병원
- 진단센터
- 세계의 디지털 게놈 시장, 시퀀싱 및 분석 기기별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 차세대 시퀀싱(NGS) 시스템
- 생어 시퀀싱 시스템
- 싱글 셀 시퀀싱 장치
- 제3세대 시퀀싱 장치
- 세계의 디지털 게놈 시장, 데이터 분석 및 관리 툴 세분화 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 바이오인포매틱스 소프트웨어
- 데이터 관리 플랫폼
- 클라우드 기반 분석 솔루션
- 워크플로우 관리 툴
제7장 지역별 및 국가별 분석
- 세계의 디지털 게놈 시장 : 지역별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 세계의 디지털 게놈 시장 : 국가별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 디지털 게놈 시장 : 경쟁 구도
- 디지털 게놈 시장 : 기업 프로파일
- Roche Holding AG : 개요, 상품 및 서비스, 전략 및 재무분석
- Thermo Fisher Scientific Inc. : 개요, 상품 및 서비스, 전략 및 재무분석
- GE HealthCare Technologies Inc. : 개요, 상품 및 서비스, 전략 및 재무분석
- Quest Diagnostics : 개요, 상품 및 서비스, 전략 및 재무분석
- Eurofins Scientific SE : 개요, 상품 및 서비스, 전략 및 재무분석
제31장 기타 주요 기업 및 혁신 기업
- Agilent Technologies Inc.
- Illumina Inc.
- bioMerieux SA
- PerkinElmer Inc.
- Bio-Rad Laboratories Inc.
- Qiagen NV
- BGI Genomics
- Myriad Genetics Inc.
- Foundation Medicine Inc.
- ArcherDx Inc.
- Invitae Corporation
- Oxford Nanopore Technologies Ltd.
- Luminex Corporation
- GenMark Diagnostics Inc.
- NanoString Technologies Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 디지털 게놈 시장(2029년) : 새로운 기회를 제공하는 국가
- 디지털 게놈 시장(2029년) : 새로운 기회를 제공하는 부문
- 디지털 게놈 시장(2029년) : 성장 전략
제36장 부록
JHS
The digital genome refers to the digitized and organized collection of an organism's genetic material, including its DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) sequences. This digital representation allows for storing, analyzing, and interpreting genetic information using computational tools and technologies. Digital genomes are essential for understanding genetic variations, disease mechanisms, and evolutionary relationships.
The main types of digital genome are sequencing and analyzer instruments, and data analysis and management tools. Sequencing and analyzer instruments refer to equipment used in genomic sequencing and analysis processes, which are essential for decoding the genetic information contained within DNA and RNA molecules. They are used for various applications such as diagnostics, agriculture and animal research, personalized medicine, drug discovery, and treatment analysis by research centers and government institutes, academic institutions, pharmaceutical and biotechnology industries, hospitals, and diagnostic centers.
The main types of digital genome are sequencing and analyzer instruments, and data analysis and management tools. Sequencing and analyzer instruments refer to equipment used in genomic sequencing and analysis processes, which are essential for decoding the genetic information contained within DNA and RNA molecules. They are used for various applications such as diagnostics, agriculture and animal research, personalized medicine, drug discovery, and treatment analysis by research centers and government institutes, academic institutions, pharmaceutical and biotechnology industries, hospitals, and diagnostic centers.
The digital genome market size has grown rapidly in recent years. It will grow from $39.25 billion in 2024 to $46.94 billion in 2025 at a compound annual growth rate (CAGR) of 19.6%. The growth in the historic period can be attributed to growing funding for genomics, reduced cost and high speed of DNA sequencing, entry of new players and start-ups in developing economies, increasing number of drug discoveries, and growing biotech sector.
The digital genome market size is expected to see rapid growth in the next few years. It will grow to $97.13 billion in 2029 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to increasing prevalence of genetic disorders, increasing research and development pertaining to digital genome, growing adoption of personalized medicine, developments in biotechnology, and rising prevalence of chronic diseases. Major trends in the forecast period include the increasing adoption of next-generation sequencing technologies, increasing technological advancements, extensive use of microorganisms in diagnostics industry, increasing demand for personalized medicines, and rising adoption of digital genomic technology by hospitals and clinics.
The increasing prevalence of genetic disorders is expected to propel the growth of the digital genome market going forward. Genetic disorders are hereditary conditions caused by abnormalities or mutations in an individual's DNA, the genetic material that carries instructions for the development and functioning of the body. Digital genome technologies enable the identification of genetic mutations and variations associated with genetic disorders. This information helps in accurate and early diagnosis of these disorders, allowing for timely intervention and treatment. For instance, in August 2023, according to the National Library of Medicine, a US-based medical library, sickle cell anemia is a genetic disease that affects approximately 1 in 500 African Americans in the United States. Further, about 1 in 12 African Americans carries the autosomal recessive mutation responsible for the disease, and approximately 300,000 infants are born with sickle cell anemia annually. Therefore, the increasing prevalence of genetic disorders is driving the growth of the digital genome market.
Major companies operating in the digital genome market are developing innovative products such as the NovaSeq X Series to understand disease and ultimately transform patient lives. NovaSeq X Series includes the NovaSeq X and NovaSeq X Plus systems, with the NovaSeq X Plus capable of sequencing more than 128 genomes per run and generating more than 20,000 whole genomes per year. For instance, in September 2022, Illumina, Inc., a US-based biotechnology company, launched the NovaSeq X Series, a significant advancement in whole-genome sequencing technology. The system incorporates cost-efficiency throughout the workflow, streamlined informatics, operational simplicity, sustainability advancements, and world-class support. It also enables broader and deeper sequencing, allowing users to scale up any application to include more samples and analyze data more efficiently. The NovaSeq X Series is designed to be the most potent and cost-effective sequencing system, with improved reagent stability and faster data transfers due to optimized genomics data compression. The system was purpose-built for improved sustainability, with a smaller data footprint that reduces storage and energy consumption costs.
In January 2023, Agilent Technologies, a US-based company specializing in analytical solutions, acquired Avida Biomed for an undisclosed amount. This acquisition is aimed at strengthening Agilent Technologies' next-generation sequencing capabilities by incorporating Avida Biomed's target enrichment workflows. Avida Biomed is a US-based life sciences company that specializes in developing advanced target enrichment workflows for next-generation sequencing (NGS).
Major companies operating in the digital genome market are Roche Holding AG, Thermo Fisher Scientific Inc., GE HealthCare Technologies Inc., Quest Diagnostics, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., BGI Genomics, Myriad Genetics Inc., Foundation Medicine Inc., ArcherDx Inc., Invitae Corporation, Oxford Nanopore Technologies Ltd., Luminex Corporation, GenMark Diagnostics Inc., NanoString Technologies Inc., Pacific Biosciences of California Inc., Genewiz, Inscripta Inc., Genomic Health Inc., Becton Dickinson and Company, GenomeMe, Regeneron Pharmaceuticals Inc.
North America was the largest region in the digital genome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital genome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the digital genome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The digital genome market consists of revenues earned by entities by providing services such as DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) isolation, profiling, qPCR, next-generation sequencing, and advanced bioinformatics data analysis pipelines. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital genome market also includes sales of sequencing and analyzer instruments, sequencing chips, sample preparation instruments, and sequencing and analysis software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Digital Genome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on digital genome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for digital genome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The digital genome market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Sequencing And Analyzer Instruments; Data Analysis And Management Tools
- 2) By Application: Diagnostics; Agriculture And Animal Research; Personalized Medicine; Drug Discovery; Treatment Analysis
- 3) By End User: Research Centers And Government Institutes; Academic Institutions; Pharmaceutical And Biotechnology Industries; Hospitals; Diagnostic Centers
- Subsegments:
- 1) By Sequencing And Analyzer Instruments: Next-Generation Sequencing (NGS) Systems; Sanger Sequencing Systems; Single-Cell Sequencing Instruments; Third-Generation Sequencing Instruments
- 2) By Data Analysis And Management Tools: Bioinformatics Software; Data Management Platforms; Cloud-Based Analysis Solutions; Workflow Management Tools
- Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; GE HealthCare Technologies Inc.; Quest Diagnostics; Eurofins Scientific SE
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Digital Genome Market Characteristics
3. Digital Genome Market Trends And Strategies
4. Digital Genome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Digital Genome Growth Analysis And Strategic Analysis Framework
- 5.1. Global Digital Genome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Digital Genome Market Growth Rate Analysis
- 5.4. Global Digital Genome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Digital Genome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Digital Genome Total Addressable Market (TAM)
6. Digital Genome Market Segmentation
- 6.1. Global Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sequencing And Analyzer Instruments
- Data Analysis And Management Tools
- 6.2. Global Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnostics
- Agriculture And Animal Research
- Personalized Medicine
- Drug Discovery
- Treatment Analysis
- 6.3. Global Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Research Centers And Government Institutes
- Academic Institutions
- Pharmaceutical And Biotechnology Industries
- Hospitals
- Diagnostic Centers
- 6.4. Global Digital Genome Market, Sub-Segmentation Of Sequencing And Analyzer Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Next-Generation Sequencing (NGS) Systems
- Sanger Sequencing Systems
- Single-Cell Sequencing Instruments
- Third-Generation Sequencing Instruments
- 6.5. Global Digital Genome Market, Sub-Segmentation Of Data Analysis And Management Tools, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bioinformatics Software
- Data Management Platforms
- Cloud-Based Analysis Solutions
- Workflow Management Tools
7. Digital Genome Market Regional And Country Analysis
- 7.1. Global Digital Genome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Digital Genome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Digital Genome Market
- 8.1. Asia-Pacific Digital Genome Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Digital Genome Market
- 9.1. China Digital Genome Market Overview
- 9.2. China Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Digital Genome Market
- 10.1. India Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Digital Genome Market
- 11.1. Japan Digital Genome Market Overview
- 11.2. Japan Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Digital Genome Market
- 12.1. Australia Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Digital Genome Market
- 13.1. Indonesia Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Digital Genome Market
- 14.1. South Korea Digital Genome Market Overview
- 14.2. South Korea Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Digital Genome Market
- 15.1. Western Europe Digital Genome Market Overview
- 15.2. Western Europe Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Digital Genome Market
- 16.1. UK Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Digital Genome Market
- 17.1. Germany Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Digital Genome Market
- 18.1. France Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Digital Genome Market
- 19.1. Italy Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Digital Genome Market
- 20.1. Spain Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Digital Genome Market
- 21.1. Eastern Europe Digital Genome Market Overview
- 21.2. Eastern Europe Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Digital Genome Market
- 22.1. Russia Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Digital Genome Market
- 23.1. North America Digital Genome Market Overview
- 23.2. North America Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Digital Genome Market
- 24.1. USA Digital Genome Market Overview
- 24.2. USA Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Digital Genome Market
- 25.1. Canada Digital Genome Market Overview
- 25.2. Canada Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Digital Genome Market
- 26.1. South America Digital Genome Market Overview
- 26.2. South America Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Digital Genome Market
- 27.1. Brazil Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Digital Genome Market
- 28.1. Middle East Digital Genome Market Overview
- 28.2. Middle East Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Digital Genome Market
- 29.1. Africa Digital Genome Market Overview
- 29.2. Africa Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Digital Genome Market Competitive Landscape And Company Profiles
- 30.1. Digital Genome Market Competitive Landscape
- 30.2. Digital Genome Market Company Profiles
- 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
31. Digital Genome Market Other Major And Innovative Companies
- 31.1. Agilent Technologies Inc.
- 31.2. Illumina Inc.
- 31.3. bioMerieux SA
- 31.4. PerkinElmer Inc.
- 31.5. Bio-Rad Laboratories Inc.
- 31.6. Qiagen N.V.
- 31.7. BGI Genomics
- 31.8. Myriad Genetics Inc.
- 31.9. Foundation Medicine Inc.
- 31.10. ArcherDx Inc.
- 31.11. Invitae Corporation
- 31.12. Oxford Nanopore Technologies Ltd.
- 31.13. Luminex Corporation
- 31.14. GenMark Diagnostics Inc.
- 31.15. NanoString Technologies Inc.
32. Global Digital Genome Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Digital Genome Market
34. Recent Developments In The Digital Genome Market
35. Digital Genome Market High Potential Countries, Segments and Strategies
- 35.1 Digital Genome Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Digital Genome Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Digital Genome Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
